Basic Information
| LncRNA/CircRNA Name | INXS |
| Synonyms | ABALON, INXS |
| Region | GRCh38_20:31721507-31723409 |
| Ensemble | ENSG00000281376 |
| Refseq | NR_131907 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | qPCR, RACE-PCR etc. |
| Sample | cell lines (THLE-3, HepG2) |
| Expression Pattern | down-regulated |
| Function Description | Tumor cell lines from kidney, liver, breast and prostate showed an endogenous INXS expression that was 5- to 9-fold lower compared with non-tumor cell lines derived from the same tissues. |
| Pubmed ID | 24992962 |
| Year | 2014 |
| Title | Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis. |
External Links
| Links for INXS | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |